Pharmaceuticals, Biotechnology and Life Sciences
WAYNE, Pa., Nov. 26, 2024 (GLOBE NEWSWIRE) — Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing…
PRINCETON, N.J., Nov. 26, 2024 (GLOBE NEWSWIRE) — ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced that…
DURHAM, N.C., Nov. 26, 2024 (GLOBE NEWSWIRE) — Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO), today announced…
SANTA ANA, Calif., Nov. 26, 2024 (GLOBE NEWSWIRE) — NKGen Biotech, Inc. (Nasdaq: NKGN) (“NKGen” or the “Company”), today announced…
DURHAM, N.C., Nov. 26, 2024 (GLOBE NEWSWIRE) — Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO), today announced…
Three-Year Term Extension Combined with Simplification and Reduction of Interest Rates Helps Further Strengthen Company’s Balance Sheet and Overall Financial…
SAN JOSE, Calif., Nov. 26, 2024 (GLOBE NEWSWIRE) — PROCEPT BioRobotics® (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused…
NEW HOPE, Pa., Nov. 26, 2024 (GLOBE NEWSWIRE) — Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”),…
CAMBRIDGE, Mass., Nov. 26, 2024 (GLOBE NEWSWIRE) — Fulcrum Therapeutics, Inc.® (the “Company”) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused…
Exploration and evaluation of strategic alternatives continueWESTPORT, Conn., Nov. 26, 2024 (GLOBE NEWSWIRE) — Portage Biotech Inc. (“Portage” or the…